Pelthos Therapeutics Inc.
PTHS
$25.11
-$0.03-0.12%
AMEX
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -16.24M | -3.45M | -1.97M | -1.93M | -1.70M |
| Total Depreciation and Amortization | 1.14M | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | 100.00 | 164.70K | 94.20K | 76.10K | 10.40K |
| Total Other Non-Cash Items | 4.87M | 413.50K | 485.80K | 530.40K | 154.50K |
| Change in Net Operating Assets | -5.03M | 2.42M | 755.40K | 650.00K | 1.35M |
| Cash from Operations | -15.26M | -447.10K | -632.10K | -670.30K | -177.70K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 2.76M | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 2.76M | -- | -- | -- | -- |
| Total Debt Issued | 68.00K | 375.00K | 250.00K | -153.80K | -897.30K |
| Total Debt Repaid | -845.00K | -- | -- | 0.00 | -200.00 |
| Issuance of Common Stock | 85.00K | -- | -- | 82.60K | 0.00 |
| Repurchase of Common Stock | -- | -- | -- | -75.00K | -- |
| Issuance of Preferred Stock | 27.38M | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | 75.00K | -74.50K |
| Cash from Financing | 26.69M | 375.00K | 250.00K | -71.20K | -972.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 14.19M | -72.10K | -382.10K | -741.50K | -1.15M |